Structural studies on 24P-IκBα peptide derived from a human IκB-α protein related to the inhibition of the activity of the transcription factor NF-κB

Biochemistry

Volumn 46, Issue 11, 2007, Pages 2958-2972

  Pons, Julien ^a   Evrard Todeschi, Nathalie ^a   Bertho, Gildas ^a   Gharbi Benarous, Josyane ^a   Sonois, Vanessa ^a   Benarous, Richard ^a   Girault, Jean Pierre ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; CYTOLOGY; ENZYME INHIBITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORYLATION;

CELLULAR SUBSTRATES; NUCLEAR FACTOR; TRANSCRIPTION FACTOR; UBIQUITIN LIGASE COMPLEX;

PEPTIDES;

ASPARTIC ACID; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; F BOX PROTEIN; GLUTAMIC ACID; GLYCINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; METHIONINE; PEPTIDE; S PHASE KINASE ASSOCIATED PROTEIN; SERINE; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DEGRADATION; HUMAN; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RANDOM COIL CONFORMATION; SIMULATION; STRUCTURE ANALYSIS; UBIQUITINATION;

AMINO ACID SEQUENCE; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; BINDING SITES; CIRCULAR DICHROISM; EPITOPE MAPPING; GENE PRODUCTS, VPU; HUMANS; I-KAPPA B PROTEINS; MODELS, MOLECULAR; NF-KAPPA B; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 33947388812     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061401f     Document Type: Article

References (61)

1. Karin, M. (1999) How NF-κB is activated: The role of the IκB kinase (IKK) complex, Oncogene 18, 6867-6874.
2. Pahl, H. L. (1999) Activators and target genes of Rel/NF-κB transcription factors, Oncogene 18, 6853-6866.
3. Barkett, M., and Gilmore, T. D. (1999) Control of apoptosis by Rel/NF-κB transcription factors, Oncogene 18, 6910-6924.
4. DeLuca, C., Kwon, H., Lin, R., Wainberg, M., and Hiscott, J. (1999) NF-κB activation and HIV-1 induced apoptosis, Cytokine Growth Factor Rev. 10, 235-253.
5. Li, Q., and Verma, I. M. (2002) NF-κB regulation in the immune system, Nat. Rev. Immunol. 2, 725-734.
6. Spencer, E., Jiang, J., and Chen, Z. J. (1999) Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP, Genes Dev. 13, 284-294.
7. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., and Ben-Neriah, Y. (1998) Identification of the receptor component of the IκBα-ubiquitin ligase, Nature 396, 590-594.
8. Hershko, A. (1983) Ubiquitin: Roles in protein modification and breakdown, Cell 34, 11-12.
9. Hershko, A., and Ciechanover, A. (1998) The ubiquitin system, Annu. Rev. Biochem. 67, 425-479.
10. Weissman, A. M. (2001) Themes and variations on ubiquitylation, Nat. Rev. Mol. Cell Biol. 2, 169-178.
11. Margottin, F., Bour, S., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R. (1998) A novel human WD protein, h-βTrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif, Mol. Cell 1, 565-574.
12. Deshaies, R. J. (1999) SCF and Cullin/Ring H2-based ubiquitin ligases, Annu. Rev. Cell Dev. Biol. 15, 435-467.
13. Fujita, K., Omura, S., and Silver, J. (1997) Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors, J. Gen. Virol. 78, 619-625.
14. Schubert, U., Anton, L. C., Cox, J. H., Bour, S., Bennink, J. R., Orlowski, M., Strebel, K., and Yewdell, J. W. (1998) CD4 glycoprotein degradation induced by human immunodeficiency virus type-1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway, J. Virol. 72, 2280-2288.
15. Latres, E., Chiaur, D. S., and Pagano, M. (1999) The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin, Oncogene 18, 849-854.
16. Margottin, F., Benichou, S., Durand, H., Richard, V., Liu, L. X., Gomas, E., and Benarous, R. (1996) Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: Role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation, Virology 223, 381-386.
17. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. (1995) Control of I κ B-α proteolysis by site-specific, signal-induced phosphorylation, Science 267, 1485-1488.
18. Nash, P., Tang, X., Orlicky, S., Chen, Q., Gertler, F. B., Mendenhall, M. D., Sicheri, F., Pawson, T., and Tyers, M. (2001) Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication, Nature 414, 514-521.
19. Zhang, J., Zheng, N., and Zhou, P. (2003) Exploring the functional complexity of cellular proteins by protein knockout, Proc. Natl. Acad. Sci. U.S.A. 100, 14127-14132.
20. Coadou, G., Gharbi-Benarous, J., Megy, S., Bertho, G., Evrard-Todeschi, N., Segeral, E., Benarous, R., and Girault, J. P. (2003) NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein β-TrCP, Biochemistry 14741-14751.
21. Megy, S., Bertho, G., Gharbi-Benarous, J., Baleux, F., Benarous, R., and Girault, J. P. (2005) STD and TRNOESY NMR studies on the conformation of the oncogenic protein β-catenin containing the phosphorylated motif DpSGXXpS bound to the β-TrCP protein, J. Biol. Chem. 280, 29107-29116.
22. Bour, S., Perrin, C., Akari, H., and Strebel, K. (2001) The human immunodeficiency virus type 1 Vpu protein inhibits NF-κ B activation by interfering with β TrCP-mediated degradation of Iκ B, J. Biol. Chem. 276, 15920-15928.
23. Besnard-Guerin, C., Belaidouni, N., Lassot, I., Segeral, E., Jobart, A., Marchal, C., and Benarous, R. (2004) HIV-1 Vpu sequesters β-transducin repeat-containing protein (βTrCP) in the cytoplasm and provokes the accumulation of β-catenin and other SCFβTrCP substrates, J. Biol. Chem. 279, 788-795.
24. Clore, G. M., and Gronenborn, A. M. (1982) Theory and applications of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bounds to proteins, J. Magn. Reson. 48, 402-417.
25. Clore, G. M., and Gronenborn, A. M. (1983) Theory of the time dependent transferred nuclear Overhauser effect: Applications to structural analysis of ligand-protein complexes in solution, J. Magn. Reson. 53, 423-442.
26. Mayer, M., and Meyer, B. (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy, Angew. Chem., Int. Ed. 38, 1784-1788.
27. Mayer, M., and Meyer, B. (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor, J. Am. Chem. Soc. 123, 6108-6117.
28. Braunschweiler, L., and Ernst, R. R. (1983) Coherence transfer by isotropic mixing: application to proton correlation spectroscopy, J. Magn. Reson. B53, 521-528.
29. Kumar, A., Ernst, R. R., and Wuthrich, K. (1980) A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules, Biochem. Biophys. Res. Commun. 95, 1-6.
30. Bodenhausen, G., and Ruben, D. J. (1980) Natural abundance N-15 NMR by enhanced heteronuclear spectroscopy, Chem. Phys. Lett. 69, 185-189.
31. Bax, A., and Summers, M. F. (1986) 1H and 13C assignments from sensitivity-enhanced detection of heteronuclear multi-bond connectivity by 2D multiple quantum NMR, J. Am. Chem. Soc. 108, 2093-2094.
32. Bax, A., and Davis, D. G. (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy, J. Magn. Reson. 65, 355-360.
33. Marion, D., Ikura, M., Tschudin, R., and Bax, A. (1989) Rapid recording of 2D NMR-spectra without phase cycling - application to the study of hydrogen-exchange in proteins, J. Magn. Reson. 85, 393-399.
34. Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored exitation for single-quantum NMR spectroscopy of aqueous solutions, J. Biomol. NMR 2, 661-665.
35. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York.
36. Meyer, B., and Peters, T. (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors, Angew. Chem., Int. Ed. 42, 864-890.
37. Nilges, M., and O'Donoghue, S. (1998) Ambigous NOES and automated NOES assignment, Prog. NMR Spectrosc. 32, 107-139.
38. Linge, J., and Nilges, M. (1999) Influence of nonbonded parameters on the quality of NMR structures: a new force field for NMR determination, J. Biomol. NMR 13, 51-59.
39. Linge, J. P., O'Donoghue, S. I., and Nilges, M. (2001) Automated assignment of ambiguous nuclear overhauser effects with ARIA, Methods Enzymol. 339, 71-90.
40. Nilges, M. (1995) Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities, J. Mol. Biol. 245, 645-660.
41. Nilges, M., Macias, M. J., O'Donoghue, S. I., and Oschkinat, H. (1997) Automated NOESY interpretation with ambiguous distance restraints: the refined NMR solution structure of the pleckstrin homology domain from β-spectrin, J. Mol. Biol. 269, 408-422.
42. Vranken, W., Tolkatchev, D., Xu, P., Tanha, J., Chen, Z., Narang, S., and Ni, F. (2002) Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface, Biochemistry 41, 8570-8579.
43. Laskowski, R. A., Rullmann, J. A. C., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR, J. Biomol. NMR 8, 477-486.
44. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: A program for display and analysis of macromolecular structures, J. Mol. Graphics 14, 51-55.
45. Wu, G., Xu, G., Schulman, B. A., Jeffrey, P. D., Harper, J. W., and Pavletich, N. P. (2003) Structure of a β-TrCP1-Skp1-β-catenin complex: Destruction motif binding and lysine specificity of the SCF(β-TrCP1) ubiquitin ligase, Mol. Cell 11, 1445-1456.
46. Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., Markley, J. L., and Sykes, B. D. (1995) 1H, 13C, and 15N chemical shift referencing in biomolecular NMR, J. Biomol. NMR 6, 135-140.
47. Ni, F. (1994) Recent developments in transferred NOE methods, Prog. Nucl. Magn. Reson. Spectrosc. 26, 517-606.
48. Verdier, L., Gharbi-Benarous, J., Bertho, G., Evrard-Todeschi, N., Mauvais, P., and Girault, J.-P. (2000) Dissociation-equilibrium constant and bound conformation for weak antibiotic binding interaction with different bacterial ribosomes, J. Chem. Soc., Perkin. Trans. 2, 2363-2371.
49. Kumar, A., Wagner, G., Ernst, R. R., and Wüthrich, K. (1981) Buildup rates of the NOE measured by 2D proton magnetic resonance spectroscopy: Implication for studies of protein conformation, J. Am. Chem. Soc. 103, 3654-3658.
50. Peng, J. W., Moore, J., and Abdul-Manan, N. (2004) NMR experiments for lead generation in drug discovery, Prog. Nucl. Magn. Reson. Spectrosc. 44, 225-256.
51. Moller, H., Serttas, N., Paulsen, H., Burchell, J. M., Taylor-Papadimitriou, J., and Meyer, B. (2002) NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3, Eur. J. Biochem. 269, 1444-1455.
52. Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., and Ballard, D. W. (1995) Signal-induced degradation of I κ B α requires site-specific ubiquitination, Proc. Natl. Acad. Sci. U.S.A. 92, 11259-11263.
53. Neer, E. J., Schmidt, C. J., Nambudripad, R., and Smith, T. F. (1994) The ancient regulatory-protein family of WD-repeat proteins, Nature 371, 297-300.
54. Yaffe, M. B., and Elia, A. E. (2001) Phosphoserine/threonine-binding domains, Curr. Opin. Cell Biol. 13, 131-138.
55. Spruck, C. H., Strohmaier, H., Sangfelt, O., Muller, H. M., Hubaleck, M., Muller-Hozner, E., Marth, C., Widschwendter, M., and Reed, S. I. (2002) hCDC4 gene mutations in endometrial cancer, Cancer Res. 62, 4535-4539.
56. Strohmaier, H., Spruck, C. H., Kaiser, P., Won, K. A., Sangfelt, O., and Reed, S. I. (2001) Human F box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line, Nature 413, 316-322.
57. β-TrCP ubiquitin ligase by hnRNP-U, Genes Dev. 16, 439-451.
58. Schubert, U., and Strebel, K. (1994) Differential activities of the human immunodeficiency virus type I-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartiments, J. Virol. 68, 2260-2271.
59. Watanabe, N., Arai, H., Nishihara, Y., Taniguchi, M., Hunter, T., and Osada, H. (2004) M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFβ-TrCP, Proc. Natl. Acad. Sci. U.S.A. 101, 4419-4424.
60. Watanabe, N., Arai, H., Iwasaki, J., Shiina, M., Ogata, K., Hunter, T., and Osada, H. (2005) Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways, Proc. Natl. Acad. Sci. U.S.A. 102, 11663-11668.
61. Kroll, M., Margottin, F., Kohi, A., Renard, P., Durand, H., Concordet, J.-P., Bachelerie, F., Arenzana-Seisdedos, F., and Benarous, R. (1999) Inducible degradation of IκBα by the proteasome requires interaction with the F-box protein h-βTrCP, J. Biol. Chem. 274, 7941-7945.